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Abstract: The use of degradable polymers in medicine largely started around the mid 20th 
century with their initial use as in vivo resorbing sutures. Thorough knowledge on this 
topic as been gained since then and the potential applications for these polymers were, and 
still are, rapidly expanding. After improving the properties of lactic acid-based polymers, 
these were no longer studied only from a scientific point of view, but also for their use in 
bone surgery in the 1990s. Unfortunately, after implanting these polymers, different 
foreign body reactions ranging from the presence of white blood cells to sterile sinuses 
with resorption of the original tissue were observed. This led to the misconception that 
degradable polymers would, in all cases, lead to inflammation and/or osteolysis at the 
implantation site. Nowadays, we have accumulated substantial knowledge on the issue of 
biocompatibility of biodegradable polymers and are able to tailor these polymers for 
specific applications and thereby strongly reduce the occurrence of adverse tissue 
reactions. However, the major issue of biofunctionality, when mechanical adaptation is 
taken into account, has hitherto been largely unrecognized. A thorough understanding of 
how to improve the biofunctionality, comprising biomechanical stability, but also 
visualization and sterilization of the material, together with the avoidance of fibrotic tissue 
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formation and foreign body reactions, may greatly enhance the applicability and safety of 
degradable polymers in a wide area of tissue engineering applications. This review will 
address our current understanding of these biofunctionality factors, and will subsequently 
discuss the pitfalls remaining and potential solutions to solve these problems.  
 
Keywords: degradable polymer; tissue engineering; mechanical loading 
 
 
1. Introduction  
 
Since the first described bone grafting procedure in 1668, when a cranial defect from an injured 
soldier was successfully repaired using a dog’s skull, considerable improvements have been made [1]. 
In addition to these improvements, the demand for bone grafting procedures is ever increasing, and the 
variety of biomaterials available to substitute bone grafts is rapidly expanding. This increased demand 
reflects the expanded surgical procedures for skeletal reconstructions (e.g. trauma, tumor excision, 
failed arthroplasty and spinal fusion) resulting in over 2 million grafting procedures annually 
worldwide [2].  
Autografting with bone, often obtained from the iliac crest, remains the “gold standard” since it 
possesses all the characteristics necessary for new bone growth, i.e. (i) osteoconductivity (passive 
scaffold to promote vascular ingrowth and bone apposition [3]), (ii) osteogenicity (containing 
osteoprogenitor cells [3]) and (iii) osteoinductivity (provide signals to induce osteogenic 
differentiations of local stem cells [3]). However, the use of autografts has its limitations, including 
predominantly donor-site morbidity (e.g. pain, hematoma, fracture and infection, but also, in particular 
in children, limited supply), hindering this as an option for bone repair [4-11]. When using donor bone 
(allografts) other disadvantages have been reported, including transmission of serious diseases from 
donor to recipient, such as HIV [12] and lymphoma [13], as well as the risk of immune rejection [14]. 
To circumvent these issues, bone grafting substitutes have become increasingly popular. The basic 
concept is that the substitute biomaterial acts as a scaffold for the surrounding cells/tissue to invade, 
grow, and thus guide tissue regeneration towards new bone formation [15-19].  
Essentially, biomaterials are designed to promote the organization, growth, and differentiation of 
cells in the process of forming functional tissue by providing structural support, biological 
containment, and chemical clues [20]. Advances in cellular biology and material technology, the 
cornerstones of tissue engineering, are increasingly influencing the clinical practice of various 
disciplines including orthopedic surgery.  
The primary function of skeletal tissues is mechanical support. When a skeletal disorder or tissue 
damage occurs, fixation is required to reposition the structures involved and to create the proper 
mechanical environment for functional healing. Once healing is achieved, however, removal is 
desirable both from a clinical and a biomechanical point of view. Therefore, degradable polymers are 
increasingly being used in tissue engineering, since they can be used as an implant and will not require 
a second surgical event for removal [21,22].  
In 1994, Freed et al. formulated six design criteria for biodegradable polymers which should be met 
in tissue engineering: (1) the surface should permit cell adhesion and growth; (2) after implantation in 
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vivo the polymer and its degradation products should not elicit inflammation or toxicity; (3) the 
polymer should be reproducibly processable into three dimensional structures; (4) high porosity for 
reducing diffusion constraints, and increasing surface area and adequate space for extracellular matrix 
regeneration; (5) the scaffold should resorb after fulfilling its purpose (since foreign materials always 
carry a risk of inflammation); and lastly (6) the degradation rate of the scaffold should match the rate 
of tissue regeneration by the cell type of interest [16].  
In bone tissue engineering not only do the interactions between degradable polymers and living 
cells play an important role, but also the interactions between these polymers and the amount and 
duration of mechanical loading it is required to support. Therefore, optimal interaction both on a 
cellular level as well as on the biomechanical level is required for a positive outcome in the formation 
of functional tissue.  
Some excellent reviews have discussed the various types of degradable polymers and their co-
polymers [22-29]. Therefore, this subject will not be discussed in detail in this review. The scope of 
this paper is to give a perspective of the facets that enter into (bone) tissue engineering using 
degradable polymers in particular. Recently, the characteristics of a degradable polymer to be 
respected prior to implantation have been divided into two main categories: biocompatibility and 
biofunctionality [30]. Biocompatibility refers to the aspects concerning the absence of toxicity, 
immunogenicity, carcinogenicity, and thrombogenicity [30]. Biofunctionality refers to the aspects of 
adequate properties (mechanical, physical, chemical, thermal and biological), easy to handle, 
sterilizable, storable and resorbable [30].  
In order to allow translation of the polymer properties to (human) tissue engineering purposes, a list 
of commonly used terms in polymer science will be provided following this paragraph. Subsequently 
degradable polymers will be addressed in two sections. The first will focus on the biocompatibility of 
degradable polymers, subdivided in foreign body response, surface characteristics and the influence of 
sterilization thereof. The second section will discuss the biofunctionality issue through visualization in 
vivo, mechanical considerations and the importance of proper mechanical testing. Finally, concluding 
remarks intending to enhance insight into the requirements needed, not only for the polymers but also 
for the various scientific fields are provided, since tissue engineering is a broad scientific field, ranging 
from cells, via biomaterials to practical solutions for treatment strategies in the human body. 
 
2. Resorbable Polymer Properties and Nomenclature  
 
Throughout this review, degradable polymers will also be referred to as polymers, to avoid 
excessive repetition. When non-degradable polymers are discussed, they will be specifically addressed 
as non-degradable.  
Polymeric scaffolds comprise two groups. The first is the group of natural occurring polymers such 
as polysaccharides (starch, alginate, hyaluronic acid) or proteins (collagen, fibrin, silk), but this review 
will focus on the second group, the synthetic bioresorbable polymers, such as the poly(α-hydroxy 
esters). 
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2.1. Molecular weight (Mn) and intrinsic viscosity  
 
Polymers are large covalent-bound chains, which typically have molecular weights between 10,000 
and 1,000,000 [31]. Since not all chains in a polymer are equally sized, a certain distribution of chain 
lengths is present in the polymer. Therefore, molecular weight is commonly represented as an average 
value. The most commonly used is the number average molecular weight (Mn), which is defined as the 
total weight of all the polymer molecules in a sample is divided by the total number of polymer 
molecules. 
Another way to identify the molecular weight of a polymer is to analyze its intrinsic viscosity IV. 
When a defined amount of polymer is dissolved to a known concentration and allowed to run through 
a capillary at a pre-set temperature under gravity, then the transit time can be recorded and compared 
with that for the pure solvent, allowing the calculation for IV [32]. Intrinsic viscosity thus relates to the 
ability of a polymer to increase the viscosity of a certain solvent at a given temperature [33].  
  
2.2. Crystallinity 
 
In general, polymers exist either as amorphous or semi‐crystalline materials. Amorphous polymers 
are composed of randomly configured chains, with no long-range order (see Figure 1). Semi-
crystalline polymers are heterogeneous systems comprised of highly anisotropic crystallites, a phase in 
which the chains show long-range 3D order (see Figure 1). The size and distribution of these crystals 
are extremely dependent on the molecular weight distribution and the conditions under which the 
material is processed. The prime factor determining whether a polymer can crystallize, is chain 
regularity since this facilitates regular stacking. The presence of more crystalline regions in a polymer 
(e.g. higher percentage of crystallinity), will result in improved mechanical properties, combined with 
slower total degradation time [34]. As crystallinization starts at multiple locations within the scaffold, 
a polymer is never fully crystalline. PLLA for example, has a maximum crystallinity of around 40%. 
 
Figure 1. A simplified model of a semi-crystalline polymer. Crystallization stops as non-
crystallised polymer length is stretched to the point that further chain movement is 
impaired. In a three dimensional polymer, this would mean "stretched out", not in a line, 
but in a random path of "lines" as it bends around neighbouring polymer chains, forming 
entanglements. 
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2.3. Thermal application range 
 
Both amorphous and semi-crystalline polymers have a limited temperature-related application 
range. The melting point (Tm) of a highly crystalline (usually non-degradable) polymer implies the 
transition from molecular order to disorder, or from crystalline to amorphous. Consequently, the Tm 
has limited value in amorphous and semi-crystalline polymers. The glass transition temperature (Tg) is 
therefore commonly used and is defined as the onset temperature of main chain segmental motion 
allowing the chains to change conformation during load. In other words; below the Tg, the molecular 
motion effectively ceases [35]. This results in a drastic change in stiffness (modulus) for amorphous 
polymers, typically from 1 GPa to 1 MPa. In contrast, the mechanical properties of semi-crystalline 
polymers above Tg are fairly preserved with elastic moduli decreasing from their original value of  
2.5–4 GPA to 500–1500 MPa. Tg can vary drastically among the various types of polymers, e.g. the Tg 
is -60 °C for polycaprolactone but 60 °C for poly(L-lactide) [21].  
 
2.4. Co-polymers 
 
All the above mentioned properties or characteristics can change when different monomers are 
co‐polymerized. These co-polymers typically take advantage of the best properties of each of the 
individual polymers. Depending on the type of co-polymerization used, combining two semi-
crystalline polymers can result in either a highly amorphous co-polymer or, due to the presence of 
homopolymeric blocks inside the co-polymer, a semi-crystalline polymer. The possibility of the 
material to be ordered into regular patterns is the causal factor in this process. Importantly, molecular 
weight, Tg, crystallinity and degradation rate can all be altered by combining different polymers 
[21,29,34] depending on the type of co-polymerization used. 
 
2.5. Degradation  
 
Degradation and erosion are not clearly distinct terms in the literature and some attempt at 
clarification has been made by claiming that degradation as a chain-scission process whereby polymers 
degrade to oligomers and finally to monomers, whereas erosion is the process of losing material due to 
oligomers and monomers leaving the polymer [36,37]. There are various types of polymer degradation 
such as photo-, thermal-, mechanical-, and chemical degradation [38]. A common denominator for all 
(non) resorbable polymers is their sensitivity to UV-light and γ-radiation with respect to erosion [38].  
An increase in molecular weight will result in more covalent bonds and thus an increased number of 
entanglements, and thereby increasing resorption/degradation time [34]. The chemical nature of 
repeating monomers forming the polymer determine the sensitivity of hydrolysable bonds [37,39]. All 
resorbable polymers contain hydrolysable bonds which are subjected to chemical degradation via 
either passive hydrolysis or enzyme-catalysed active hydrolysis [39]. For most synthetic polymers, 
passive hydrolysis is the most important mode of degradation [38,39]. The process of degradation 
generally occurs through surface erosion and/or bulk erosion. Surface erosion occurs on the surface of 
the polymer and is related to the impossibility of water to penetrate the polymer in large 
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concentrations. This leads to decreased external dimensions of the implant. All polymers are subject to 
this type of erosion, but particularly when the implant has a small pore size or a high hydrophobicity 
[32,38]. Passive hydrolysis is more active in amorphous polymers, or in the amorphous regions in 
semi-crystalline polymers than in the crystalline regions. This implies that the amorphous region of a 
polymer degrades faster, leaving the crystalline part to constitute most of the polymer over time. Bulk 
erosion occurs when water penetrates the implant and breaks the hydrolysable bonds in the backbone 
of the polymer. In addition to these types of degradation, a process known as autocatalysis can occur, 
when acids (e.g. lactic or glycolic) are formed and thus lower the local pH during degradation [37-39]. 
When acid production exceeds metabolism, this increased acidity leads to accelerated degradation of 
the implant [34]. Which way a polymer matrix erodes or degrades depends mainly on: (I) the chemical 
structure of the polymer (i.e.: the covalent bonds that make up the backbone); (II) the intrusion of 
water inside the matrix; (III) the local pH; and (IV) the dimensions of the matrix [28,37,38].  
Finally, the indiscriminate use of the terms biodegradable, bioabsorbable and bioresorbable in 
literature cause considerable confusion, due to the absence of standard terminology [27]. The term 
biodegradable can be used for materials that break down in vivo, but are not proven to be eliminated 
from the body, or when the mechanism of degradation is unknown [27,39]. Bioresorbable and 
bioabsorbable should be used when the polymer is eliminated from the body via either metabolization 
(to CO2 and H2O) or because the oligomers are degraded to a size allowing excretion via the  
kidney [27].  
 
3. Biocompatibility 
 
Biocompatibility of a material refers to “the ability of a material to perform with an appropriate host 
response in a specific situation” [40]. It involves not only the material used, but also the surrounding 
cells/tissue. The interaction of biomaterials and cells is very complex, and only partially understood 
[41]. To understand the possibilities to orchestrate the biomaterial-cell reactions, a elucidation of their 
interactions is needed.  
For the allowance of initially cell-free polymers to elicit infiltration of cells, this interaction is of 
pivotal importance. Under physiological conditions, cells will, amongst others, bind to the surrounding 
extracellular matrix via ligands. Many proteins interact with cells and thereby evoke a myriad of 
responses [42]. Since the recognition of biomaterials by a cell is typically mediated by proteins  
[19,43-46], preadsorption of specific proteins (or small peptides such as Arg-Gly-Asp; RGD) has been 
investigated to improve cellular response [43,47,48]. In general, enhancing the biocompatibility of a 
biomaterial can be achieved by altering the surface characteristics of the substrate, which in turn can 
lead to enhancing or reducing protein adsorption [43].  
 
3.1. Foreign body reaction and fibrous tissue formation 
 
Foreign body reaction is defined as a “response of a host to the presence of a foreign body” [49]. 
Furthermore it is explained that this reaction is “neither a single event nor a simple process but a broad 
concept and a multifactorial phenomenon” [49]. This cascade starts chronologically with the 
injury/implantation, followed by blood-material interactions. This interaction initiates blood protein 
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deposition on the polymer surface, which is described as a provisional matrix. Recently, Wilson et al., 
reviewed this biomaterial-cell interactions via adsorbed proteins [47]. This matrix provides the 
structural, cellular and biochemical cues for either the wound healing process or the foreign body 
reaction (FBR). These reactions are for the most part identical, but distinguished by the presence of a 
foreign body [50]. Anderson et al., provides a thorough overview of foreign body reactions to 
biomaterials [51]. Briefly, in the case of FBR, the acute and chronic inflammatory responses are to 
follow successively. The chronic FBR for resorbable materials will resolve after full degradation [52].  
Since the surface properties can determine the provisional matrix present on the polymer, which 
consequently can determine the extent or the FBR, the importance of surface properties and protein 
adsorption has been recognized. Especially the inflammatory cell population, monocytes/macrophages 
and foreign body giant cells (FBGC; which are fused macrophages and occur when particles are too 
large for phagocytosis [52]) are key players, dictated by the provisional matrix (for excellent 
overviews see Refs. [51-53]), In this perspective the wettability of a surface can positively increase the 
biocompatibility in vitro, since hydrophilic (and anionic) surfaces have been shown to demonstrate (i) 
limited adhesion of macrophages (ii) an increased level of apoptosis in adhered macrophages and (iii) 
a reduced amount of macrophage fusion into FBGCs [54,55] Lastly, degradation of resorbable 
polymers, such as L-lactide-based polymers, show a non-linear loss of mass, resulting in a increased 
release of acidic components, possible leading to inflammatory reactions, if not metabolized or drained 
off quickly enough [56]. In addition, certain degradble polymers can exhibit increased crystallinity 
during storage at room temperature when compared to storage at 4 °C [57], possible increasing the risk 
for FBR after implantation. 
In some cases granulation tissue precedes the fibrous encapsulation of the implant [51]. Fibrosis can 
be a major challenge to overcome in tissue engineering. Abundant local production of transforming 
growth factor-ß (TGF-ß) is the main cause of fibrosis and results in the extensive production of 
collagens type I and III [52]. Furthermore, TGF-ß initiates differentiation of fibroblast-like cells to 
myofibroblasts, cells not only critical to wound healing, but also initiators of the formation of fibrotic 
tissue around the implant [52]. Whether or not the encapsulation occurs and the intensity of the FBR is 
related to the dimensions of the injury, the biocompatibility of the material, the coverage of provisional 
matrix and, importantly, the tissue or organ into which the device is implanted [51]. The latter has 
been established by implanting the polymers PLA and poly(desaminotyrosyl-tyrosine ethyl carbonate) 
(poly(DTE-carbonate)) in either subcutaneous pouches or in bony defects [58-60]. When implanted in 
a subcutaneous pouch, both polymers exhibited fibrous encapsulation [59], but when implanted into 
bone, only PLA presented a fibrous tissue lining layer at the bone-implant interface [60]. Moreover, 
when implanting poly(DTE carbonate) and poly(desaminotyrosyl-tyrosine butyl carbonate) (poly(DTB 
carbonate)), which have very closely matched chemical structure and material properties, in a bony 
defect, a dramatic differences in fibrous encapsulation was observed, to the detriment of poly(DTB 
carbonate) [60]. Animal experiments carried out in our group, in which we implanted a resorbable co-
polymer in either bone or in a subcutaneous pouch has shown that the extent of the FBR and the 
formation of fibrous encapsulation is determined by the anatomical location of the implant site with 
unfavorable results for the subcutaneous pouch (see Figure 2). Another observation regarding fibrous 
tissue in all our large animal fusion studies, is the fibrous tissue layer surrounding the outer rim of the 
spinal cage, with the thickest layer at the load-bearing edges of the cage. Since micro-motion through 
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the spinal motion segment before interbody fusion is unavoidable [61,62], we suspect that the 
inevitable micro-motion is responsible for the fibrous tissue layer due to cellular shear stress. 
 
Figure 2. Fibrous encapsulation with clear deformation of the polymer cage filler. The 
dotted square represents the original size prior to implantation (18 x 10 mm). Retrieval 
after 6 months.  
 
 
 
For semi-crystalline resorbable polymers, an additional remark has to be made. High crystallinity of 
the oligomer (low molecular weight fractions that result from degradation and that easily crystallize) can lead 
to fibrous encapsulation when implanted subcutaneously [59]. Late inflammatory responses can occur, 
since the amorphous region of a polymer is degraded the earliest [32], leaving the degradation-resistant 
crystals to invoke a FBR [27,32,63].  
 
3.2. Surface characteristics and sterilization 
 
It is known that cells are sensitive to subtle differences in surface characteristics [46] and by 
analysing the surface characteristics and/or modifications, such as topography, chemistry and 
hydrophilicity in relation to the behavior of cells, more aspects in cell/biomaterial interaction have 
been clarified [46,64-67]. An extensive assessment of stem cell/biomaterials combinations has, for 
example, been performed by Neuss et al. [41]  
The topography of the surface of the substrate, which can vary (or can be varied) from macro to 
micro, can determine the response of cells which are typically 10-100 μm in diameter [42]. For non-
resorbable orthopaedic implants, the effect of the surface roughness (often referred to as root mean 
square (RMS), representing an average of the peaks and valleys of the surface) on the cellular response 
and on the bone-implant interface is being delineated [46,68-70]. In general, increased surface 
roughness is associated with decreased proliferation and increased differentiation of the cells [69]. 
More accurately, it is found that the response of the cell is cell-type specific and roughness dependent. 
It has been shown that osteoblasts and bone marrow cells preferably attach to and proliferate on 
rougher surfaces, while fibroblasts and epithelial cells prefer smoother and extreme smooth surfaces 
respectively [46,71,72]. This might indicate cell specific preferences with respect to surface roughness 
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for their tissue of origin. In this respect, Thapa et al. recently showed an increased bladder smooth 
muscle cell adhesion to a resorbable polymer by mimicking the topography of native bladder  
tissue [73].  
Another variable characteristic of the substrate surface is the hydrophilicity or wettability. An 
increased hydrophilicity of the polymer as a cell substrate leads to increased cell attachment and 
higher proliferation rates of the cultured cells [74,75]. Furthermore, for bone tissue engineering 
purposes, it has been stated that an increase in substrate wettability will result in an increased activity 
of alkaline phosphatase (ALP, indicating osteogenic potential of the cultured cells), not only for 
osteoblasts [76,77] but also for mesenchymal stem cells [64,78]. However, contradictory results in 
other studies, showed an inverse relation with ALP activity of cultured cells and the wettability 
[79,80]. Moreover, the hydrophilicity of a substrate can also affect the host response in vitro by 
altering the cellular reaction of a immune responsive white blood cell, the monocyte. With greater 
hydrophilicity, not only lower amounts of monocytes attached to the surface but also increased 
apoptosis (programmed cell death) occured for the adhered monocyte fraction [54,55]. Therefore, the 
hydrophilicity of the polymer could potentially be used to reduce immune responses in vivo.  
Irrespective of the biomaterial used, sterilization is mandatory for clinical usage, but the method 
used can substantially affect the physical/mechanical properties of bioabsorbable polymers [81,82]. 
The Tg of many polymers would be exceeded during hospital steam sterilization and their physical and 
mechanical properties thus altered, making this technique unsuitable for resorbable polymers [83].  
For heat sensitive polymers, ethylene-oxide sterilization can be used. Ethylene-oxide (EtO) gas 
sterilization is a direct alkylating method and therefore a microbiological inactivator.[84] EtO has been 
shown to leave the physical and structural properties of the bioabsorbable polymer poly(beta-hydroxy 
octanoate) unaltered [85]. Since EtO does not involve the radiation by particles, it is more likely to 
preserve original wettability and surface roughness properties of the bulk polymer.  
In contrast, some sterilization techniques and/or sterilizing agents can specifically be used to alter 
the surface roughness and hydrophilicity of the surface. Simply immersing polymers in alkaloids 
and/or ethanol can lead to effective improvement of the surface [86,87]. Other common procedures of 
surface functionalization include plasma treatment or glow discharge capable of increasing the 
wettability of (resorbable) polymers by creating reactive sites via the interaction of ionized molecules 
with the polymer [75]. An increased wettability, as achieved by glow discharge, could likewise be 
induced in our experiments [80] by using clinically applied electron-beam sterilization. Our increased 
wettability of the polymer after e-beam sterilization is in accordance with increased hydrophilicity of 
the ceramic hydroxyapatite [88] and various (non-resorbable) polymers [89], due to surface oxidation 
in a dose dependent manner. Since sterilization of the substrate is mandatory before clinical 
application, the proper technique should be evaluated, since some techniques, like e-beam, can achieve 
additional positive outcomes for surface functionalization, while care should be taken since the 
mechanical properties of the polymer can simultaneously be affected. 
Since sterilization can affect not only the mechanical properties, but also the surface properties of 
polymers, affecting the cell-material interaction, the complete sequence of the production of the 
polymer, including sterilization, should be evaluated prior to pre-clinical testing. 
In summary, the biocompatibility of resorbable implants could be at risk by causing long-term 
complications, such as local osteolysis, the formation of sterile sinuses and fibrous encapsulation 
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[21,32,90-98]. The intensity of this host tissue response is influenced by implant related factors e.g. 
surface properties, polymer type, purity, crystallinity, design and processing techniques. Since the last 
decade, many groups were able to show good bio(osteo)compatibility for various polymers for bone 
tissue engineering in vivo [98-101]. Recently, bioresorbable polymers have been used to correct 
cranio-facial deformities in a multi-center EU trial [102]. For self-reinforced PLA, Ashammakhi et al., 
reported very low prevalence (0.1%) of clinically manifested inflammatory reactions [100]. A recent 
overview on the use of polymers in clinical trials has been written by Pietrzak et al. [32].   
 
4. Biofunctionality 
 
When bony tissues fail due to trauma or disease, additional support is required to take over their 
mechanical function. For example, in spinal diseases causing degeneration, instability and/or severe 
deformations, spinal fusion of the segments may be needed. Devices used for this purpose should not 
only maintain or restore the spinal anatomy, but also create the proper mechanical environment for 
bony fusion. The load bearing device for interbody spinal fusion is the so-called cage, which usually is 
supplied with a load-transducing filler material. As bones and implants must resist considerable loads, 
metals and/or alloys are popular load-bearing materials used for cages. 
Metals and/or alloys have proven to be successful, although drawbacks do exist. In spinal surgery, 
amongst others, permanent materials such as metals (and non-resorbable polymers) remain susceptible 
to long-term complications such as migration [103], wear [61], late foreign body reaction [61,104] and 
infection [105]. The inflammatory reaction is, in some cases, the result of the inevitable corrosion of 
alloys in vivo (often referred to as particle disease), and also in the spine [106,107]. In other cases, the 
aforementioned micro-motion through the spinal motion segment may lead to particle debris [22]. 
Therefore strategies to minimize implant related problems have been devised such as removal of the 
implant after fulfilling its purpose in every patient [108], or to selectively remove the implant in 
symptomatic patients [95], which in return can cause neurovascular injury or refracture [95]. In the 
USA, retrieval surgeries of the spine were reported in 25-40% of the patients [109-111]. Furthermore, 
metallic spinal implants are strongly radiopaque on roentgenograms, which is the most widely used 
follow-up imaging after spinal surgery [112] (see Figure 3). This results in an obscured view and 
therefore hampered assessment of fusion, since the presence of a bony bridge throughout the spinal 
implant can not be seen [112-115]. Not only do metals/alloys interfere with simple x-ray films, they 
will therefore also interfere with computer axial tomography scanning (CAT) and cause artefacts 
(scattering) with magnetic resonance imaging (MRI) [100] In contrast, the presence of a bony bridge 
on a plain roentgenogram in radiolucent spinal implants can be visualized and does correlate with 
surgical exploration, considered the gold standard [116]. Radiolucent spinal implants are generally 
made from non-degradable polymers such as polyetheretherketone (PEEK) and will also not interfere 
with CAT scans or MRI scans. However, in a similar fashion as metallic cages, non-degradable cages 
will remain susceptible to similar long-term complications. Development of degradable spinal cages 
will not only result in optimal assessment of spinal fusion during follow-up using x-ray films (see 
Figure 4), CAT scans or MRI scans, but also avert potential long-term complications, resulting in a 
patient-friendly and cost-effective treatment option. 
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Figure 3. A postoperative lateral roentgenogram of an explanted goat spine with the 
placement of a radiolucent cage (a) and a titanium cage (b). 
a b
 
 
Figure 4. Lateral roentgenogram of a goat, using both a radiolucent cage and polymer cage 
filler (a) directly postoperative and (b) prior to sacrifice, 6 months after surgery, in which 
bone formation in the cage, indicated by the white arrows, can be seen. 
a
b
 
  
Finally, when an incommensurate amount of load is directed through the load-bearing implant, the 
chance of achieving bony fusion decreases and can result in fragile, thin bone trabeculae or non-union 
[117]. This so-called stress shielding can occur due to the discrepancy between the much higher 
stiffness of the metallic implant compared to that of vertebral bone [117-120]. In this respect, a higher 
stiffness can work contra productive. In our goat spinal fusion studies we found that a ‘flexible’ PLLA 
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cage (axial compression stiffness (ACS): 2 kN/mm) contained significant higher percentage of 
lamellar bone compared to the ‘stiff’ PLLA cage(ACS:4 kN/mm) after 6 months in vivo [121]. In the 
same study, a higher rate of fusion was detected for the PLLA cages when compared to the titanium 
cages after 6 months [121].  
Mechanical strength should be considered carefully when using resorbable implants, since polymers 
have limited strength compared to metals. When designing degradable implants it is important to 
realize the type and magnitude of load the implant is expected to support. An implant can therefore act 
as a non-load bearing or load-transducing scaffold for cells to grow in, or can function as a load 
bearing scaffold, expected to maintain mechanical stability and integrity. This dichotomy between 
non-load bearing and load bearing requires different polymer properties. Usually, glassy degradable 
polymers are being used for load-bearing properties. Degradable bone screws and plates, made of 
these glassy polymers, have yielded good results in recent research [32], and despite the fact that the 
spine is among the most difficult anatomical locations in the body to achieve fusion [32], polymer 
implants have achieved spinal fusion in vivo [32,119,121-124]. 
The human skeleton –in particular the spine and long bones- is subjected to relatively large 
dynamic loading ranges and polymers appear to degrade faster under such conditions [21,125]. Too 
early loss of mechanical integrity results in instability of the spinal segment and ultimately in non-
unions and clinical failure [122]. Moreover, glassy polymers show a strong time- and load-dependent 
behavior [108]. In our own animal spinal fusion experiments, we have experienced this behavior, since 
the mechanical strength of the co-polymeric cage, was lower for lower (!) loading rates, higher 
temperature and higher humidity [126]. Since many materials (e.g metal) can endure any static load 
below the yield strength almost indefinitely, tests concerning static loading are uncommon and not 
routinely performed on polymers. Therefore, despite the preliminary compressive mechanical tests 
according to the American Society for Testing and materials (ASTM) standards (F2077-03) [122], to 
our surprise, premature failure of the interbody fusion cages was observed within less than 5 minutes 
(!) when statically loaded at 75% of their strength, indicating the need to reconsider the standards for 
mechanical testing of strongly time-dependent materials [126]. The elucidation of these problems for 
resorbable polymers is clearly explained by Govaert et al. [108] In addition to static loading, the 
aforementioned ASTM test also requires a perfect fit for interbody fusion devices in the holder during 
testing. In a clinical setting, a perfect fit is rare, but rather unproblematic for metallic devices. For 
polymeric cages, the absence of a perfect fit results in concentrations in tensile stress due to three-
point bending and subsequent brittle failure. In the animal experiments of Krijnen et al., we have 
experienced advanced mechanical degradation of resorbable lumbar interbody fusion cages due to e-
beam sterilization as compared to ethylene-oxide sterilization [82,122]. Smit et al., showed that for in 
vitro experiments, e-beam induced a loss of molecular weight by a factor three, when compared to 
EtO. This equals an EtO sterilized cage after about 11.5 months of degradation [82].  
Since living bone is a self-optimizing tissue through mechanical adaptation [118,127,128], bone in 
itself is the optimal mechanical support. Therefore skeletal devices should essentially have a 
temporary function and should subsequently be removed both from a clinical and biomechanical point 
of view, once healing is achieved. Degradable polymers can be tailored to match the stiffness of bone 
[120], do not interfere with several imaging techniques [129] and degrade over time in which the 
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mechanical load can be gradually transferred from the resorbable implant to newly formed tissue [130] 
and eliminating the potential need for removal surgery. 
Since 1996, our group has pursued this ‘temporary’ skeletal engineering approach for the spine, and 
it has resulted in the development of a bioabsorbable implant, which is currently in clinical evaluation 
[22,82,121,126,131-133].  
 
5. Emerging Technologies 
 
Despite the potential pitfalls in bone tissue engineering when using degradable polymers, many 
caveats are being delineated and advantages are increasingly being recognized by clinicians. As a 
result, the market for degradable polymers in surgery continues to grow. When using degradable 
polymers in surgery for bone repair, its cost-effectiveness has been demonstrated in several studies, 
not only due to the omission of removal surgery, but also due to the decrease in sick-leave time and the 
number of radiographs taken [100,134,135]. After implantation, Sinisaari and colleagues detected 
lower infection rates for degradable fixation devices in ankle surgery when compared to their metallic 
counterparts [136,137].  
More recently, a new generation of implants is emerging with the possibility of incorporating 
antibiotic substances in the polymers which will be released in a controlled manner during 
degradation. Implants made of polyglycolide-co-polylactide (PLGA) and PDLA are currently being 
studied in animal models to assess the risk of infection after implantation [100,136-141]. Combining 
the function of scaffold and controlled release system holds great potential for degradable polymers, 
not only for antibiotic substances, but also for various growth factors (e.g. vascular endothelial growth 
factor, bone morphogenetic proteins), thereby possibly shortening the bone healing process [26,31]. 
Another example of these are aliphatic polyesters like polyhydroxybutyrate (PHB) which are produced 
by micro-organisms. Their major degradation product, hydroxybutyric acid, is naturally found in 
human blood. The PHB homopolymer is highly crystalline and brittle; this can be overcome by 
copolymerizing with polyhydroxyvalerate (PHV) to reduce crystallinity from 80 to 35% and to 
increase failure strain from 8-50%. Mechanical properties of polymers thus can be improved in order 
to meet requirements of specific implantation sites.  
Degradable scaffolds for bone tissue engineering not only should meet requirements on material 
properties, but also geometric specifications have to be fulfilled. In general, the higher the porosity and 
the pore-size of the scaffold, the greater the bone ingrowth in vivo [31]. A porosity of at least 80-90% 
[142,143] and a pore-size of at least 300 μm [144,145] are recommended due to improved bone 
formation and the formation of capillaries, pivotal for nutrient support. Various technologies are 
available for that, such as salt-leaching techniques or —for more regular shapes— polymer  
printing technology.  
A novel design approach for scaffolds is biomimetic design. In order to mimic the extracellular 
matrix (ECM), nanofiber-based scaffolds, prepared by electrospinning, contain fibers in nano-scale 
range which resemble biological fibers in the extra cellular matrix [146]. Nanofiber based polymeric 
scaffolds have shown increased cell attachment, and higher alkaline phosphatase activity when 
compared to matrices without nanofibers [146]. Other biomimetic design approaches include the 
incorporation of synthesized forms of the calcium phosphates naturally occurring in bone in polymers 
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[26]. These so-called composite scaffolds present several advantages. Firstly, during degradation of the 
polymer, a lowering of the pH may occur. This increased acidity can be buffered by the calcium 
phosphate, thus dampening the acidic polymer degradation [26]. Secondly, slight increase in stiffness 
and strength was found for composites when compared to the polymer alone [26]. Thirdly, by 
incorporating calcium phosphates, direct bone apposition can occur at the polymer-bone interface 
[147] (osteoconduction), preventing the unfavorable fibrous encapsulation of the scaffold [60]. In 
contrast to incorporating calcium phosphates it has recently been shown that after surface 
functionalization of the polymer via hydrolysis, a chemically bonded calcium phosphate coating 
(crystalline apatite [148]) can be generated. Cowan et al., has shown increased bone formation in mice 
cranial defects after implanting osteoblast seeded, pre-mineralized PLGA scaffolds when compared to 
osteoblast seeded, but not pre-mineralized PLGA scaffolds [149].  
With the increased interest in minimally invasive surgery, patients experience less pain, reduced 
scarring and tissue injury, and shortened hospital time. A major disadvantage of this development is 
that the smaller openings in the patients make it more difficult to insert an implant or to knot a suture. 
To address this issue, degradable elastic shape memory polymers may be of use, that can take a certain 
shape upon thermal or optic induction [56,150]. These polymers may be introduced in a compressed or 
bent form and obtain the appropriate shape upon induction. Various polymers can be used for this 
purpose, including PCL-co-PLLA (PCLA), PDLLA-hydroxyapatite composites, and copolyester-
urethane networks [151,152]. 
The possibilities of degradable polymers are steadily increasing and in fact are currently 
overwhelming. Material design traditionally starts with the synthesis of a new material, which is then 
characterized chemically, biologically and mechanically, and then a suitable application can be 
identified. Computational modeling may speed up this process by predicting the behavior of polymers 
under various conditions. Libraries containing thousands of individual polymer compositions can be 
used to predict material characteristics like elastic modulus, degradation time, and glass-transition 
temperature as a function of the manufacturing process and implantation time [153,154]. Also the 
time-dependent properties of polymers under static and dynamic loading conditions can be predicted 
[108]. Using such databases, design factors like shape, surface topography and chemical composition 
can be controlled to ensure that implants will meet the appropriate requirements of the specific 
application. Furthermore, customized implants can be created by freeform fabrication and polymer 
scaffold libraries [155-159]. Solid freeform fabrication allows for 3D printing of custom designs using 
CAD drawings. Polymer scaffold libraries allow determining appropriate cell-scaffold combinations 
that will be successful in tissue engineering applications. Polymer expert systems such as these will 
prove helpful if not mandatory in designing new implants of degradable polymers and thereby enhance 
the tissue engineering process. 
 
6. Conclusions 
 
The early papers on resorbable polymers demonstrated quite some adverse effects, causing negative 
publicity and barring of degradable polymers from clinical evaluation. With our increased knowledge 
of the principle pathways causing these effects, many adverse effects have been clarified and can be 
avoided. The orchestration of an appropriate host tissue response is not only guided by the 
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biocompatibility (intrinsic) issues of the polymer but also by the biofunctionality issues, which we 
consider to be the implantation site, the vascularization of the scaffold, the presence/absence of micro-
motion, the dynamic loading regime and the visualization in vivo. Critical biocompatibility problems, 
such as fibrous encapsulation has been studied extensively, and can likely be circumvented via direct 
bone apposition at the surface. Despite the fact that the biofunctionality of degradable polymers such 
as mechanical loading of polymeric scaffolds requires further investigation as well as adaptation of 
mechanical testing of materials, pivotal biofunctionality issues are often overlooked. 
Since degradable polymers are part of a comprehensive field of research, a multidisciplinary 
approach is crucial and the convergence of various scientific fields should lead to a cost-effective, 
patient-friendly strategy to treat bone defects. Once pre-mineralization, growth factor release systems 
and other biomimetic approaches are clinically available, and have had proper mechanical test runs, 
degradable polymers will get their second chance in clinical practice. Computational modeling will be 
helpful in selecting appropriate polymers out of thousands of candidates stored in libraries and predict 
their properties during manufacturing and their behavior after implantation over the degradation 
process.  
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